Comparison between Agilus Diagnostics IPO and Groww IPO.
Agilus Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Groww IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Agilus Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the Groww IPO is up to ₹6,632.30 Cr. The final issue price of Agilus Diagnostics IPO is and of Groww IPO is ₹100.00 per share.
| Agilus Diagnostics IPO | Groww IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹95.00 per share | |
| Issue Price (Upper) | ₹100.00 per share | |
| Issue Price (Final) | ₹100.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 150 shares | |
| Fresh Issue Size | 0 shares | 10,60,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,060.00 Cr |
| OFS Issue Size | 1,42,33,964 shares | 55,72,30,051 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹5,572.30 Cr |
| Issue Size Total | 1,42,33,964 shares | 66,32,30,051 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹6,632.30 Cr |
Agilus Diagnostics IPO opens on , while Groww IPO opens on Nov 04, 2025. The closing date of Agilus Diagnostics IPO and Groww IPO is , and Nov 07, 2025, respectively.
| Agilus Diagnostics IPO | Groww IPO | |
|---|---|---|
| Anchor Bid Date | Nov 03, 2025 | |
| Issue Open | Nov 04, 2025 | |
| Issue Close | Nov 07, 2025 | |
| Basis Of Allotment (Tentative) | Nov 10, 2025 | |
| Initiation of Refunds (Tentative) | Nov 11, 2025 | |
| Credit of Share (Tentative) | Nov 11, 2025 | |
| Listing date (Tentative) | Nov 12, 2025 | |
| Anchor Lockin End date 1 | Dec 09, 2025 | |
| Anchor Lockin End date 2 | Feb 07, 2026 |
Agilus Diagnostics IPO P/E ratio is , as compared to Groww IPO P/E ratio of 33.26.
| Agilus Diagnostics IPO | Groww IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Billionbrains Garage Ventures Ltd.'s revenue increased by 45% and profit after tax (PAT) rose by 327% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.68 | 28.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 27.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹61735.97 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.17% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.61% | 37.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Agilus Diagnostics IPO Retail Individual Investors (RII) are offered while in Groww IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Agilus Diagnostics IPO and 19,89,69,016 shares in Groww IPO.
| Agilus Diagnostics IPO | Groww IPO | |
|---|---|---|
| Anchor Investor Reservation | 29,84,53,523 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 19,89,69,016 shares | |
| NII | 9,94,84,507 shares | |
| RII | 6,63,23,005 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 66,32,30,051 shares |
Agilus Diagnostics IPO subscribed in total, whereas Groww IPO subscribed 17.60x.
| Agilus Diagnostics IPO | Groww IPO | |
|---|---|---|
| QIB (times) | 22.02x | |
| NII (times) | 14.20x | |
| Big NII (times) | 16.28x | |
| Small NII (times) | 10.04x | |
| RII (times) | 9.43x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 17.60x |
